Neurology Grand Rounds

Kinne Auditorium

Monday March 21, 2016 at 12:15 PM

Video-conferenced to Nemours 1 North & Mayo Clinic Health System in Waycross

Wolfdieter Springer, Ph.D., presents “Mitochondrial Quality Control in Parkinson’s Disease – From Mechanisms to Biomarker and Drug Discovery”  at Neurology Grand Rounds 12:15 PM on March 21, 2016

The research interests of Wolfdieter Springer, Ph.D., revolve around cell biology in aging and age-dependent disorders. His primary research focus is on the molecular and cellular mechanisms underlying the pathogenesis of Parkinson's disease and other related neurodegenerative disorders.

Dr. Springer's lab takes a combinatorial approach using biochemistry, cell biology and advanced imaging techniques, such as multicolor live cell and high-content microscopy. His lab aims to identify novel genetic and chemical modifiers in cell-based assays, as well as in vivo using C. elegans as a screening tool.

Learning Objectives:

Define areas of new neuroscience knowledge and research

Understand Clinicopathologic (CPC) correlations of neurologic disease

Illuminate areas of practice-based improvement within the neurosciences based on advancing scientific research or Practice-based improvement projects.

The speaker does not have a relevant financial relationship, and does not intend to discuss off label/investigative use of a commercial product or device.

College of Medicine, Mayo Clinic, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

College of Medicine, Mayo Clinic, designates this live CME activity for a maximum of 1.0 AMA PRA Category 1 Credits^RM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is supported in part by an educational grant from the following companies in accordance with ACCME Standards:  NONE